Advertisement
Screener

Generate Biomedicines, Inc. (GENB) Graph

GENB Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2021-08-31: Research and development $10.00M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

GENB revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$6.31MOperating expenses$77.93MOperating income-$71.61MResearch & development$64.33MPre-tax income-$67.20MIncome tax$53.00KNet income-$67.26M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endResearch and development
2021-08-31$10.00M

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$6.31M$64.33M$77.93M$53.00K-$67.25M
2026-03-31$7.22M$57.81M$71.34M$28.00K-$61.45M
2025-06-30$10.13M$59.73M$70.28M$44.00K-$52.43M
2025-03-31$8.82M$46.83M$56.97M$56.00K-$41.69M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$13.54M$122.14M$149.26M$81.00K-$128.70M
2025-06-30$18.95M$106.56M$127.25M$100.00K-$94.11M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Biohaven Ltd. (BHVN)United States$1.990B-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38